IBD

0.0(0)
Studied by 3 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/58

encourage image

There's no tags or description

Looks like no tags are added yet.

59 Terms

1
New cards

what is the mechanism of action of 5-aminosalicylates

  • modulates local medicators of inflammation (leukotrienes)


2
New cards

5-aminosalicylates should be avoided in patients with ______ allergy

  • sulfa


3
New cards

which 5-aminosalicylate needs to be taken with folic acid daily?

a) sulfasalazine

b) balsalazide

c) olsalazine

d) mesalamine

a) sulfasalazine

4
New cards

sulfasalazine ADE

  • low tolerability → increased GI effects

  • can affect male fertility

    • reversible oligospermia


5
New cards

which forms of mesalamine are dosed daily

  • mesalamine ER cap (Apriso)

  • mesalamine DR tab (Asacol HD, Lialda)


6
New cards

5-ASA indication

  • mild-moderate UC for induction of remission and maintenance therapy


7
New cards

T/F: 5-ASAs should not be used in pregnancy

  • false

    • safe to use in pregnancy


8
New cards

which systemic corticosteroid can consider taking a PPI due to GI side effects?

a) methylprednisolone

b) hydrocortisone

c) prednisone

d) budesonide

c) prednisone

9
New cards

prednisone and methylprednisolone counseling

  • take with food

    • bc of insomnia risk

  • limit salt intake (water retention)


10
New cards

which systemic corticosteroid should avoid grapefruit juice?

a) methylprednisolone

b) hydrocortisone

c) prednisone

d) budesonide

d) budesonide

11
New cards

corticosteroid indication

  • flare treatment and remission induction for moderate-severe disease

  • symptom control while immunomodulators or biologics become effective


12
New cards

steroid use in pregnancy

  • limit when possible

    • budesonide > prednisone


13
New cards

immunomodulator indication

  • Crohn’s maintenance

    • NOT INDUCTION

  • UC maintenance (azathioprine/6-MP ONLY)


14
New cards

SATA: which immunomodulators need TPMT testing prior to initiation?

a) azathioprine

b) 6-mercaptopurine

c) methotrexate

a) azathioprine

b) 6-mercaptopurine

15
New cards

why do patients need TPMT testing for azathioprine and 6-mercaptopurine?

  • TPMT = main enzyme in their metabolism

    • deficient in TPMT = increased risk for major negative ADE (pancreatitis, myelosuppression, hepatotoxicity)


16
New cards

how should azathioprine and 6-mercaptopurine be used in pregnancy?

  • safe to continue in preganncy

  • do NOT START in pregnancy

    • major negative ADE (pancreatitis, myelosuppression, hepatotoxicity)


17
New cards

azathioprine and 6-mercaptopurine should not be given with what drug?

  • allopurinol


18
New cards

T/F: immunomodulators have immediate clinical benefit

  • false

    • can take up to 12 wks to see clinical benefit


19
New cards

which immunomodulator is teratogenic?

a) azathioprine

b) 6-mercaptopurine

c) methotrexate

c) methotrexate

20
New cards

which immunomodulator needs daily folic acid?

a) azathioprine

b) 6-mercaptopurine

c) methotrexate

c) methotrexate

21
New cards

SATA: which immunomodulators can be used in the maintenance of UC?

a) azathioprine

b) 6-mercaptopurine

c) methotrexate

a) azathioprine

b) 6-mercaptopurine

22
New cards

why are immunomodulators recommended as combination therapy with anti-TNFs

  • helps reduce formation of anti-drug antibodies

  • boosts anti-TNF drug levels

  • recommended in both guidelines


23
New cards

anti-TNF resistance

  • can form abs against the anti-TNF drugs → resistance


24
New cards

anti-TNF MOA

  • bind to human TNF-alpha → inhibits TNF-alpha from binding to receptor sites

    • decreases cytokine-driven inflammatory processes


25
New cards

which biologic (Anti-TNF) has the highest risk for infusion reactions

a) infliximab

b) adalimumab

c) certolizumab

d) golimumab

a) infliximab

  • CHIMERIC


26
New cards

which biologic (Anti-TNF) is weight-based dosed for IV?

a) infliximab

b) adalimumab

c) certolizumab

d) golimumab

a) infliximab

27
New cards

what is the primary ADE of the biologics (Anti-TNF)?

  • injection site reactions (all injectable)


28
New cards

which biologic (Anti-TNF) is used for CD ONLY?

a) infliximab

b) adalimumab

c) certolizumab

d) golimumab

c) certolizumab


29
New cards

which biologic (Anti-TNF) is used for UC ONLY?

a) infliximab

b) adalimumab

c) certolizumab

d) golimumab

d) golimumab

30
New cards

adalimumab ADE

  • headache at beginning of treatment

    • will resolve later


31
New cards

anti-TNF drug induced ADE…

  • can happen immediately or long term

    • drug-induced lupus

    • drug-induced psoriasis


32
New cards

Anti-TNF black box warning

  • serious infection

    • greatest when taken concomitant with immunosuppressants

  • malignancy (lymphoma)


33
New cards

what labs are taken for anti-TNFs at the start and throughout treatment?

  • at start

    • QuantiFERON TB

    • hepatitis B S ag

  • throughout

    • CBC w/ diff

    • LFTs

    • anti-drug antibodies


34
New cards

anti-TNFs should be used with caution in patients with…

  • hisotry of demyelinating disease

  • HF

  • HIV

  • seizures

  • leukemia/lymphoma


35
New cards

what if a patient was found to be a latent TB carrier before starting anti-TNFs ?

  • treat for 4 weeks before starting ant-TNFs


36
New cards

what immunomodulator is preferred in young males (<35) due to the others having malignancy risk (HSTCL)?

  • use methotrexate


37
New cards

what anti-TNFs are effective in treating fistulizing Crohn’s disease?

  • infliximab

  • adalimumab

  • certolizumab


38
New cards

AGA recommends _____ and ______ over certolizumab in biologic naive patients

  • infliximab and adalimumab


39
New cards

anti-TNF indications

  • first line therapy “top-down”

  • mod-severe UC (induction & maintenance)

  • mod-severe CD resistant to corticosteroids / refractory to immunomodulators


40
New cards

how are interleukin inhibitors tolerated?

  • well tolerated

    • upper respiratory infection


41
New cards

how are interleukin inhibitors dosed?

  • loading dose → maintenance dose


42
New cards

which interleukin inhibitor is said to be a “dual inhibitor” (p19 subunit and CD-64 subunit)

a) Ustekinumab

b) Risankizumab

c) Mirikizumab

d) Guselkumab

d) Guselkumab

43
New cards

IL-23 inhibitor labs before starting and throughout treatment

  • before starting

    • quantiferon TB

    • hepatitis B S ag

  • throughout

    • CBC

    • LFTs

    • drug level (Ustekinumab ONLY)


44
New cards

which interleukin inhibitor needs annual skin exams because of increased skin cancer risk?

a) Ustekinumab

b) Risankizumab

c) Mirikizumab

d) Guselkumab

a) Ustekinumab

45
New cards

SATA: which interleukin inhibitors are safe to use throughout pregnancy?

a) Ustekinumab

b) Risankizumab

c) Mirikizumab

d) Guselkumab

a) Ustekinumab

b) Risankizumab

c) Mirikizumab

  • Guselkumab collection still ongoing


46
New cards

ustekinumab indication

  • moderate-severe CD or UC in patients who have failed steroids, immunomodulators, or anti-TNFs


47
New cards

Risankizumab, mirikuzumab, guselkumab indication

  • moderate-severe CD or UC

    • can be biologic naive OR failed multiple therapies


48
New cards

vedolizumab MOA

  • anti-integrin

    • binds to alpha-4b7 integrin

      • blocks reaction with MadCAM-1 → inhibits migration of memory T lymphocytes across inflamed gut tissue


49
New cards

vedolizumab indication

  • induction & maintenance in mod-sevre CD and UC


50
New cards

T/F: vedolizumab onset of clinical response can be slower than anti-TNFs

  • true


51
New cards

what vaccine is necessary for JAK inhibitors

  • HZV vaccine

    • shingles can be triggered by JAK inhibitors


52
New cards

what is the major ADE of Tofacitinib (JAK inhibitor)

  • thrombosis

    • applied to class because of FDA


53
New cards

what is the major ADE of Updacitinib (JAK inhibitor)

  • acne

    • dose-dependent


54
New cards

JAK inhibitor black box waning

  • thrombosis & sudden CV death

    • only tofacitinib studied, but FDA mandated application to class of drugs


55
New cards

JAK inhibitor indication

  • induction & maintenance of remission in mod-severe active UC

    • for PTS W/ ANTI-TNF FAILURE/INTOLERANCE


56
New cards

T/F: JAK inhibitors are safe to use in pregnancy

  • false


57
New cards

S1P modulator contraindications

  • CVD

    • history of MI, unstable angina, etc

  • not recommended in hepatic impairment


58
New cards

S1P modulator indication

  • induction and maintenance of remission in mod-severe active UC


59
New cards

general trend of medication classes to try

  • thiopurine / anti-TNF combo + steroids →

  • thiopurine →

  • anti-TNF →

  • JAKi →

  • S1PR →

  • vedo; anti-IL